ENG/中
美国
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
医美概念股
625.159
+9.249
1.50%
手动刷新
涨家数:
5
跌家数:
6
平家数:
2
市盈率:
- -
高:
633.963
开:
614.939
低:
614.113
收:
615.910
数据加载中...
总览
新闻
聚焦创新与国际化发展,上海生物医药行业迈入集群化、高质量发展新阶段
上观新闻
·
02-24
瑞丽医美盘中异动 快速拉升6.73%报0.111港元
市场透视
·
02-24
复星医药再出手!频频减持山河药辅 累计套现逾1.2亿元
读创客户端
·
02-24
山河药辅:股东拟减持不超过3%公司股份
中国财富网
·
02-24
复锐医疗科技盘中异动 快速跳水5.26%报3.600港元
市场透视
·
02-24
山河药辅:股东复星医药因经营需要拟减持不超过3%公司股份
观点网
·
02-23
山河药辅(300452.SZ)股东复星医药拟减持不超3%股份
智通财经
·
02-23
【山河药辅:股东复星医药拟减持不超过3%公司股份】山河药辅公告,股东上海复星医药产业发展有限公司因经营需要,计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股,即不超过公司总股本的3%。
金融界
·
02-23
【上海市工商联生物医药商会揭牌,陈启宇当选首任会长】2月22日,上海市工商联生物医药商会第一届一次会员会议暨生物医药发展大会在闵行区虹桥西郊庄园丽笙大酒店举行。上海市工商联生物医药商会正式揭牌,办公落地闵行区,上海复星医药股份有限公司非执行董事陈启宇当选首任会长。
金融界
·
02-23
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1593/news?page=9"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":625.15894,"timestamp":1741594084363,"preClose":615.91016,"halted":0,"volume":102329963,"delay":0,"changeRate":0.015016,"change":9.248779,"pbRate":1.190795,"amount":775101220,"amplitude":0.03223,"prevYearClose":571.87146,"fiveDayClose":604.125,"twentyDayClose":578.349,"turnoverRate":0.005049,"marketCap":112033200160,"floatMarketCap":74569710368,"peRate":21.56404},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":633.96344,"amplitude":0.03223,"preClose":615.91016,"low":614.11285,"pbRate":"1.190795","latestPrice":625.15894,"volume":102329963,"delay":0,"open":614.9391,"prevYearClose":571.87146,"prevWeekClose":615.91,"prevMonthClose":612.07,"prevQuarterClose":571.871,"fiveDayClose":604.125,"twentyDayClose":578.349,"sixtyDayClose":582.226,"secType":"PLATE","market":"HK","turnoverRate":0.005049,"peRate":21.56404,"marketCap":112033200160,"floatMarketCap":74569710368,"timestamp":1741594084363,"nameCN":"医美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":5,"down":6,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:16,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2513714095","title":"聚焦创新与国际化发展,上海生物医药行业迈入集群化、高质量发展新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2513714095","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513714095?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 16:07","pubTimestamp":1740384476,"startTime":"0","endTime":"0","summary":"此次大会的召开,标志着上海生物医药行业将不断迈入集群化、高质量发展新阶段。陈启宇会长在任职演讲中表示,成立上海市工商联生物医药商会不仅是上海生物医药行业的里程碑,更是推动行业高质量发展的新起点。上海已汇聚一大批优秀的民营生物医药企业,创新与国际化发展大有可为。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022416061398908903&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022416061398908903&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","02196","600196","BK1593"],"gpt_icon":0},{"id":"2513147798","title":"瑞丽医美盘中异动 快速拉升6.73%报0.111港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513147798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513147798?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 09:41","pubTimestamp":1740361306,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘09时41分,瑞丽医美股票出现波动,股价大幅上涨6.73%。截至发稿,该股报0.111港元/股,成交量10万股,换手率0.02%,振幅6.73%。资金方面,该股资金流入8320港元,流出0港元。瑞丽医美股票所在的医疗及医学美容服务行业中,整体涨幅为0.05%。其相关个股中,瑞丽医美、脑动极光-B、固生堂涨幅较大,振幅较大的相关个股有健康之路、讯飞医疗科技、瑞丽医美,振幅分别为16.00%、10.65%、6.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022409414698902e65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022409414698902e65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","02135","BK1209"],"gpt_icon":0},{"id":"2513798794","title":"复星医药再出手!频频减持山河药辅 累计套现逾1.2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513798794","media":"读创客户端","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513798794?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 09:41","pubTimestamp":1740361299,"startTime":"0","endTime":"0","summary":"山河药辅表示,复星医药拟减持时间为2025年3月18日至6月15日,拟减持价格根据减持时市场价格及相关规定确定,不低于发行价。目前,复星医药持有山河药辅2392.81万股,占该公司总股本比例为10.20%,为其第二大股东。近年来,复星医药多次出手减持。以此计算,复星医药套现约2770.27万元。另据iFind数据统计,2018年—2020年,复星医药7次减持山河药辅,累计套现约9800万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224095519962dd60c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224095519962dd60c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02196","BK1515","BK1593"],"gpt_icon":0},{"id":"2513601267","title":"山河药辅:股东拟减持不超过3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2513601267","media":"中国财富网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513601267?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 09:33","pubTimestamp":1740360832,"startTime":"0","endTime":"0","summary":"根据公告,复星医药目前持有山河药辅股份23,928,059股,占公司总股本的10.20%。此次减持计划涉及不超过6,978,000股,占公司总股本的3%。复星医药表示,此次减持的主要原因是根据其自身经营需要,获取投资收益。公告还提到,复星医药在山河药辅首次公开发行时的股份锁定和减持承诺已履行完毕,未出现违反承诺的行为。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224094444a2513e6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224094444a2513e6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1593","BK1515","02196"],"gpt_icon":0},{"id":"2513760811","title":"复锐医疗科技盘中异动 快速跳水5.26%报3.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513760811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513760811?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 09:30","pubTimestamp":1740360634,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘09时30分,复锐医疗科技股票出现异动,股价急速跳水5.26%。截至发稿,该股报3.600港元/股,成交量12.28万股,换手率0.03%,振幅5.00%。资金方面,该股资金流入8904港元,流出40.3096万港元。复锐医疗科技股票所在的医疗设备及用品行业中,整体涨幅为0.05%。其相关个股中,先瑞达医疗-B、心通医疗-B、微泰医疗-B涨幅较大,振幅较大的相关个股有复锐医疗科技、堃博医疗-B、爱康医疗,振幅分别为5.00%、3.66%、3.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224093034989029f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224093034989029f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1585","BK1100","01696"],"gpt_icon":0},{"id":"2513759975","title":"山河药辅:股东复星医药因经营需要拟减持不超过3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2513759975","media":"观点网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513759975?lang=zh_cn&edition=fundamental","pubTime":"2025-02-23 23:11","pubTimestamp":1740323511,"startTime":"0","endTime":"0","summary":"观点网讯:山河药辅2月23日公告,股东上海复星医药产业发展有限公司因经营需要,计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股,即不超过公司总股本的3%。 山河药辅表示,公司生产经营情况正常。本次拟减持股份的股东不属于公司的控股股东或实际控制人,本次股份减持不会导致公司控制权发生变更,不会对公司治理结构、股权结构及持续性经营产生影响。免责声明:本文内容与数据由观点根据公开信息整理,不构成投资建议,使用前请核实。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/23231148332588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0188","BK1191","BK0177","BK1515","BK0183","BK0012","02196","BK0187","300452","BK0196","600196","BK0096","BK0028","BK0060","BK0175","BK1593"],"gpt_icon":0},{"id":"2513130758","title":"山河药辅(300452.SZ)股东复星医药拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2513130758","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513130758?lang=zh_cn&edition=fundamental","pubTime":"2025-02-23 22:00","pubTimestamp":1740319219,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山河药辅(300452.SZ)发布公告,持股10.20%的股东上海复星医药产业发展有限公司(以下简称“复星医药”)因经营需要,拟自公告发布之日起15个交易日后90日内(2025年3月18日至2025年6月15日)以集中竞价交易方式和大宗交易方式合计减持公司股份不超过697.8万股,即不超过公司总股本的3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0177","BK0239","BK1515","300452","BK0028","BK0060","BK1191","BK0187","600196","BK0096","02196","BK0012","BK0183","BK0188","BK1593","BK0175","BK0196"],"gpt_icon":0},{"id":"2513730339","title":"【山河药辅:股东复星医药拟减持不超过3%公司股份】山河药辅公告,股东上海复星医药产业发展有限公司因经营需要,计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股,即不超过公司总股本的3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513730339","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513730339?lang=zh_cn&edition=fundamental","pubTime":"2025-02-23 21:10","pubTimestamp":1740316201,"startTime":"0","endTime":"0","summary":"山河药辅公告,股东上海复星医药产业发展有限公司因经营需要,计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股,即不超过公司总股本的3%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/23211048332439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0096","BK0239","02196","BK0183","BK0012","BK0177","BK0188","BK1515","BK1593","BK0196","BK0028","BK0187","BK0060","300452","BK0175","BK1191","600196"],"gpt_icon":0},{"id":"2513735708","title":"【上海市工商联生物医药商会揭牌,陈启宇当选首任会长】2月22日,上海市工商联生物医药商会第一届一次会员会议暨生物医药发展大会在闵行区虹桥西郊庄园丽笙大酒店举行。上海市工商联生物医药商会正式揭牌,办公落地闵行区,上海复星医药股份有限公司非执行董事陈启宇当选首任会长。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513735708","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513735708?lang=zh_cn&edition=fundamental","pubTime":"2025-02-23 16:55","pubTimestamp":1740300954,"startTime":"0","endTime":"0","summary":"2月22日,上海市工商联生物医药商会第一届一次会员会议暨生物医药发展大会在闵行区虹桥西郊庄园丽笙大酒店举行。上海市工商联生物医药商会正式揭牌,办公落地闵行区,上海复星医药股份有限公司非执行董事陈启宇当选首任会长。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/23165548332126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1593","BK0239","399441","BK0060","BK0183","BK0012","BK1191","600196","02196","BK0096","BK0028","BK0187","BK0175","BK1164","00045","161726","BK0188","BK0196","BK1515"],"gpt_icon":0}],"pageSize":16,"totalPage":9,"pageCount":9,"totalSize":137}]}}